Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2568708 | 0.82 | ADORA3 (0.37) | ADORA3ADORA2AADORA2B | |
| SCHEMBL31121823 | 0.79 | ADORA3 (0.34) | ADORA3ADORA2AADORA2BKMT2AATM | |
| SCHEMBL13624500 | 0.79 | MMP1 (0.38) | KMT2A | |
| SCHEMBL26167886 | 0.78 | KMT2A (0.34) | ADORA3ADORA2AADORA2BKMT2AATM | |
| SCHEMBL12922784 | 0.78 | ADORA3 (0.31) | ADORA3ADORA2AADORA2B | |
| SCHEMBL16314439 | 0.78 | ADORA3 (0.36) | ADORA3ADORA2AADORA2B | |
| SCHEMBL2607876 | 0.76 | ADORA3 (0.37) | ADORA3ADORA2AADORA2BKMT2A | |
| SCHEMBL12743131 | 0.76 | ADORA3 (0.33) | ADORA3ADORA2AADORA2B | |
| SCHEMBL13323678 | 0.76 | ADORA3 (0.33) | ADORA3ADORA2AADORA2B | |
| SCHEMBL14644902 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2023-10-19 | — | — | US | disclosed |
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | ADORA3 2161/4885ADORA2A 3156/4885ADORA2B 4313/4885 |
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | ADORA3 2161/4885ADORA2A 3156/4885ADORA2B 4313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.